8-K

NutriBand Inc. (NTRB)

8-K 2024-01-25 For: 2024-01-21
View Original
Added on April 05, 2026

SECURITIES

AND EXCHANGE COMMISSION

Washington,

DC 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of

the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 21, 2024

Nutriband,

Inc.

Nevada 000-40854 81-1118176
(State or Other Jurisdiction<br><br> of Incorporation) (Commission File Number) (I.R.S. Employer<br><br> Identification No.)
121<br> S. Orange Ave. Suite 1500<br><br> <br>Orlando,<br> Florida 32801
--- ---
(Address of Principal Executive<br> Offices) (Zip Code)

(407)

377-6695

Registrant’s

Telephone Number, Including Area Code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications<br> pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant<br> to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications<br> pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communications<br> pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common<br> Stock NTRB The Nasdaq<br> Stock Market LLC
Warrants NTRBW The Nasdaq<br> Stock Market LLC

Item 5.07

Submission of Matters to a Vote of Security Holders.

The Company’s 2023 Annual Meeting of Stockholders was held on January 21, 2024, in Orlando, Florida. At the meeting two proposals were on the agenda for approval by the Company’s stockholders: election of six directors and ratification of the engagement of Sadler, Gibb & Associates, LLC as the Company’s independent audit firm for fiscal 2023. In addition, the non-binding “say on pay” vote on approval of executive compensation and the “say on frequency” vote on the frequency of the say on pay vote were voted on by the stockholders. The results of the stockholder votes on each of these proposals is set forth below.


At the 2023 Annual Meeting, the stockholders elected the six candidates nominated by the Company’s Board of Directors to serve as directors for one-year terms, each until his or her successor is duly elected and qualified.

The table below presents the results of the shareholder votes at the annual meeting on election of six directors, and of the votes as to ratification of the selection of the Company’s audit firm for 2023, and the votes on “say on pay” on executive compensation and “say on frequency” of the shareholder say on pay votes.:

Director Name Total Votes For Votes Withheld Votes Against Votes Abstain Broker Non- Vote
Gareth Sheridan **** 5,299,587 46,785 - - 400,979
Serguei Melnik **** 5,282,321 64,051 - - 400,979
Mark Hamilton **** 5,235,220 111,152 - - 400,979
Radu Bujoreanu **** 5,248,479 97,893 - - 400,979
Stefani Mancas **** 5,303,429 42,943 - - 400,979
Irina Gram **** 5,253,489 92,883 - - 400,979
Proposal Total<br><br>Votes For Votes Withheld Votes Against Votes Abstain Broker Non-  Vote
--- --- --- --- --- --- --- --- --- --- ---
Ratify the Selection of Sadler, Gibb & Associates 5,720,198 27,097 56 -
Advisory Approval of Executive Compensation 5,299,717 46,012 637 400,985
Advisory Approval on Frequency of Exec Comp - 1 Yr 5,319,922 - - 7,117 400,979
Advisory Approval on Frequency of Exec Comp - 2 Yr 1,334 - - - 400,979
Advisory Approval on Frequency of Exec Comp - 3 Yr 17,999 - - - 400,979
1

SIGNATURES

PURSUANT

TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

NUTRIBAND, INC.
Date: January 25, 2024 By: /s/ Gareth<br> Sheridan
R: Gareth Sheridan
Chief Executive Officer

2